资讯
9 天on MSN
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
A study presented at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Apr. 21, 2025 — An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler ...
Tuberculosis clustering is commonly reported in Ethiopia, but most studies rely on registered data, which may miss patients who do not visit health facilities or those who attend but are not ...
12 天
News-Medical.Net on MSNAI-powered lung ultrasound outperforms human experts in diagnosing tuberculosisA pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).
5 天
News Medical on MSNStudy Suggests Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment ...In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...
9 天
Newspoint on MSNStomach TB is more dangerous than lung TB, know how to identify the arrival of this enemyTB can occur in the stomach as well as in the lungs. It occurs due to the spread of bacteria of lung TB. According to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果